Europe Sperm Separation Devices Market - Industry Trends and Forecast to 2029

TABLE OF CONTENT

TABLE OF CONTENTS
1 INTRODUCTION 52
1.1 OBJECTIVES OF THE STUDY 52
1.2 MARKET DEFINITION 52
1.3 OVERVIEW OF THE EUROPE SPERM SEPARATION DEVICES MARKET 52
1.4 LIMITATIONS 54
1.5 MARKETS COVERED 54
2 MARKET SEGMENTATION 57
2.1 MARKETS COVERED 57
2.2 GEOGRAPHICAL SCOPE 58
2.3 YEARS CONSIDERED FOR THE STUDY 59
2.4 CURRENCY AND PRICING 59
2.5 DBMR TRIPOD DATA VALIDATION MODEL 60
2.6 MULTIVARIATE MODELLING 63
2.7 END USER LIFELINE CURVE 63
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 64
2.9 DBMR MARKET POSITION GRID 65
2.10 MARKET APPLICATION COVERAGE GRID 67
2.11 VENDOR SHARE ANALYSIS 68
2.12 SECONDARY SOURCES 69
2.13 ASSUMPTIONS 69
3 EXECUTIVE SUMMARY 70
4 PREMIUM INSIGHTS 73
4.1 PORTERS FIVE FORCES 75
4.2 PESTEL ANALYSIS 76
5 INDUSTRIAL INSIGHTS 77
6 EUROPE SPERM SEPARATION DEVICES MARKET: REGULATIONS 78
6.1 REGULATION IN THE U.S. 78
6.1.1 GUIDELINES FOR MANUFACTURER 78
6.2 REGULATION IN EUROPE 79
6.2.1 GUIDELINES FOR MANUFACTURERS 79
6.3 REGULATION IN CANADA 79
6.3.1 GUIDELINES FOR MANUFACTURERS 79
6.4 REGULATION IN SOUTH AFRICA 80
6.4.1 GUIDELINES FOR MANUFACTURERS 80
7 MARKET OVERVIEW 81
7.1 DRIVERS 83
7.1.1 INCREASE IN INCIDENCE OF INFERTILITY IN MEN AND WOMEN 83
7.1.2 RISE IN THE IVF, INTRAUTERINE INSEMINATION (IUI), AND INTRA-CERVICAL INSEMINATION (ICI) 83
7.1.3 INCREASE IN HEALTHCARE EXPENDITURE 84
7.1.4 STRATEGIC INITIATIVES TAKEN BY VARIOUS MARKET PLAYERS 85
7.2 RESTRAINTS 85
7.2.1 HIGH COST OF SPERM SEPARATION DEVICES 85
7.2.2 STRICT REGULATORY 86
7.3 OPPORTUNITIES: 86
7.3.1 RISE IN NUMBER OF RESEARCH AND DEVELOPMENT ACTIVITIES 86
7.3.2 INCREASING PUBLIC AWARENESS ABOUT THE FERTILITY 87
7.4 CHALLENGES 88
7.4.1 COMPLICATIONS AND SIDE EFFECTS ASSOCIATED WITH PROCEDURES AND DEVICES 88
7.4.2 SHORTAGE OF SKILLED PERSONNEL 88
8 EUROPE SPERM SEPARATION DEVICES MARKET, BY DEVICES 89
8.1 OVERVIEW 90
8.2 CENTRIFUGATION-FREE DEVICES 93
8.2.1 BY TYPE 93
8.2.1.1 MIGRATION-SEDIMENTATION (MS) 94
8.2.1.2 MICROFLUIDIC SPERM SORTERS (MFSS) 94
8.2.2 BY DESIGN TYPE 94
8.2.2.1 STANDARD 94
8.2.2.2 OBLIQUE 94
8.2.2.3 COIL 94
8.2.3 BY VOLUME 95
8.2.3.1 LESS THAN 1ML 95
8.2.3.2 1-3 ML 95
8.2.3.3 MORE THAN 3 ML 95
8.2.4 BY TECHNOLOGY 95
8.2.4.1 MICROFLUIDIC 96
8.2.4.2 PHOTONIC 96
8.2.4.3 OTHERS 96

8.3 CENTRIFUGATION DEVICES 96
8.3.1 BY TYPE 97
8.3.1.1 DENSITY GRADIENT (DG) SEPARATION 97
8.3.1.2 SWIM UP (SU) 97
8.3.2 BY DESIGN TYPE 97
8.3.2.1 STANDARD 97
8.3.2.2 OBLIQUE 97
8.3.2.3 COIL 98
8.3.3 BY VOLUME 98
8.3.3.1 LESS THAN 1ML 98
8.3.3.2 1-3 ML 98
8.3.3.3 MORE THAN 3 ML 98
8.3.4 BY TECHNOLOGY 98
8.3.4.1 MICROFLUIDIC 99
8.3.4.2 PHOTONIC 99
8.3.4.3 OTHERS 99
9 EUROPE SPERM SEPARATION DEVICES MARKET, BY MEDIA 100
9.1 OVERVIEW 101
9.2 SPERM FREEZING MEDIA 104
9.3 SPERM PROCESSING MEDIA 104
9.4 SPERM WASHING MEDIA 105
9.5 OTHER MEDIA 106
10 EUROPE SPERM SEPARATION DEVICES MARKET, BY ASSISTED DEVICES 107
10.1 OVERVIEW 108
10.2 IMAGING SYSTEMS 111
10.3 INCUBATOR 111
10.4 CABINET 112
10.5 OTHERS 113
11 EUROPE SPERM SEPARATION DEVICES MARKET, BY TECHNOLOGY 114
11.1 OVERVIEW 115
11.2 ELECTROPHORESIS 118
11.3 DIELECTROPHORESIS 118
11.4 ON-CHIP 119

12 EUROPE SPERM SEPARATION DEVICES MARKET, BY APPLICATION 120
12.1 OVERVIEW 121
12.2 FERTILITY 124
12.2.1 IN-VITRO FERTILIZATION 125
12.2.2 INTRAUTERINE INSEMINATION 125
12.2.3 INTRA-CERVICAL INSEMINATION 125
12.3 FORENSICS 125
12.4 DIAGNOSTICS 126
12.5 OTHERS 127
13 EUROPE SPERM SEPARATION DEVICES MARKET, BY DISTRIBUTION CHANNEL 128
13.1 OVERVIEW 129
13.2 DIRECT TENDER 132
13.3 THIRD PARTY DISTRIBUTORS 132
13.4 OTHERS 133
14 EUROPE SPERM SEPARATION DEVICES MARKET, BY END USER 134
14.1 OVERVIEW 135
14.2 IVF LABORATORIES 138
14.3 HOSPITALS 138
14.4 FERTILITY CENTERS 139
14.5 CLINICS 140
14.6 RESEARCH INSTITUTES 140
14.7 CRYOBANKS 141
14.8 SURGICAL CENTERS 142
14.9 OTHERS 143
15 EUROPE SPERM SEPARATION DEVICES MARKET, BY GEOGRAPHY 144
15.1 EUROPE 145
15.1.1 GERMANY 158
15.1.2 FRANCE 164
15.1.3 U.K. 171
15.1.4 ITALY 177
15.1.5 SPAIN 184
15.1.6 TURKEY 190
15.1.7 RUSSIA 196
15.1.8 NETHERLAND 203
15.1.9 SWITZERLAND 209
15.1.10 BELGIUM 216
15.1.11 REST OF EUROPE 223
16 EUROPE SPERM SEPARATION DEVICES MARKET: COMPANY LANDSCAPE 224
16.1 COMPANY SHARE ANALYSIS: EUROPE 224
17 COMPANY PROFILE 225
17.1 THE COOPER COMPANIES INC. 225
17.1.1 COMPANY SNAPSHOT 225
17.1.2 REVENUE ANALYSIS 225
17.1.3 COMPANY SHARE ANALYSIS 226
17.1.4 PRODUCT PORTFOLIO 226
17.1.5 RECENT DEVELOPMENTS 226
17.2 BONRAYBIO CO., LTD 228
17.2.1 COMPANY SNAPSHOT 228
17.2.2 COMPANY SHARE ANALYSIS 228
17.2.3 PRODUCT PORTFOLIO 229
17.2.4 RECENT DEVELOPMENT 229
17.3 MENICON CO., LTD. 230
17.3.1 COMPANY SNAPSHOT 230
17.3.2 REVENUE ANALYSIS 230
17.3.3 COMPANY SHARE ANALYSIS 231
17.3.4 PRODUCT PORTFOLIO 231
17.3.5 RECENT DEVELOPMENTS 231
17.4 MEMPHASYS 232
17.4.1 COMPANY SNAPSHOT 232
17.4.2 REVENUE ANALYSIS 232
17.4.3 COMPANY SHARE ANALYSIS 233
17.4.4 PRODUCT PORTFOLIO 233
17.4.5 RECENT DEVELOPMENTS 233
17.5 SAR HEALTHLINE PVT LTD 234
17.5.1 COMPANY SNAPSHOT 234
17.5.2 COMPANY SHARE ANALYSIS 234
17.5.3 PRODUCT PORTFOLIO 235
17.5.4 RECENT DEVELOPMENT 235
17.6 DXNOW 236
17.6.1 COMPANY SNAPSHOT 236
17.6.2 PRODUCT PORTFOLIO 236
17.6.3 RECENT DEVELOPMENT 236
17.7 GYNOTEC 237
17.7.1 COMPANY SNAPSHOT 237
17.7.2 PRODUCT PORTFOLIO 237
17.7.3 RECENT DEVELOPMENT 237
17.8 HAMILTON THORNE, LTD. 238
17.8.1 COMPANY SNAPSHOT 238
17.8.2 REVENUE ANALYSIS 238
17.8.3 PRODUCT PORTFOLIO 239
17.8.4 RECENT DEVELOPMENTS 239
17.9 KOEK BIOTECHNOLOGY BIOENGINEERING AND MEDICAL SERVICES INDUSTRY & TRADE INC. 240
17.9.1 COMPANY SNAPSHOT 240
17.9.2 PRODUCT PORTFOLIO 240
17.9.3 RECENT DEVELOPMENT 240
17.10 NIDACON INTERNATIONAL AB 241
17.10.1 COMPANY SNAPSHOT 241
17.10.2 PRODUCT PORTFOLIO 241
17.10.3 RECENT DEVELOPMENT 241
17.11 PROMEGA CORPORATION 242
17.11.1 COMPANY SNAPSHOT 242
17.11.2 PRODUCT PORTFOLIO 242
17.11.3 RECENT DEVELOPMENT 242
17.12 SEAFORIA 243
17.12.1 COMPANY SNAPSHOT 243
17.12.2 PRODUCT PORTFOLIO 243
17.12.3 RECENT DEVELOPMENT 243
17.13 SPERM PROCESSOR PVT LTD. 244
17.13.1 COMPANY SNAPSHOT 244
17.13.2 PRODUCT PORTFOLIO 244
17.13.3 RECENT DEVELOPMENT 244
18 QUESTIONNAIRE 245
19 RELATED REPORTS 248